Investigating NfL and GFAP in the blood of individuals with bipolar depression could provide valuable insights into the extent of neuronal pathology and astrocyte activation associated with the disorder, providing new avenues for therapeutic strategies. This evidence concerns the gene GFAP and bipolar disorder.